Marvell Technology, Inc. vs NVIDIA Corporation — Stock Comparison
Q·Score Breakdown
7.6
Buy
Overall
9.1
Strong Buy
Quality
Health
Growth
Valuation
Sentiment
MRVL
Earnings growing 106% year-over-year on 22% revenue growth.
⚠ analysts see limited upside from current price.
NVDA
Clean balance sheet with low leverage (0.1× debt-to-equity).
Analyst Consensus
BUY
Target $128.36 (-21.8%)
39 analysts
BUY
Target $269.17 (+33.7%)
57 analysts
Fundamentals
MRVL
NVDA
53.5×
Trailing P/E
41.1×
30.3×
Forward P/E
17.9×
32.6%
Profit Margin
55.6%
51.0%
Gross Margin
71.1%
19.3%
ROE
101.5%
22.1%
Revenue Growth
73.2%
106.3%
Earnings Growth
95.6%
1.82
Beta
2.33
—
Price / Book
—
$143.5B
Market Cap
$4.89T
$54 – $171
52-Week Range
$111 – $217
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load.